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Abstract
Cadmium (Cd), a toxic environmental contaminant, induces oxidative stress, leading to neurodegenerative disorders.
Recently we have demonstrated that Cd induces neuronal apoptosis in part by activation of the mitogen-activated protein
kineses (MAPK) and mammalian target of rapamycin (mTOR) pathways. However, the underlying mechanism remains
elusive. Here we show that Cd elevated intracellular calcium ion ([Ca
2+]i) level in PC12, SH-SY5Y cells and primary murine
neurons. BAPTA/AM, an intracellular Ca
2+ chelator, abolished Cd-induced [Ca
2+]i elevation, and blocked Cd activation of
MAKPs including extracellular signal-regulated kinase 1/2 (Erk1/2), c-Jun N-terminal kinase (JNK) and p38, and mTOR-
mediated signaling pathways, as well as cell death. Pretreatment with the extracellular Ca
2+ chelator EGTA also prevented
Cd-induced [Ca
2+]i elevation, MAPK/mTOR activation, as well as cell death, suggesting that Cd-induced extracellular Ca
2+
influx plays a critical role in contributing to neuronal apoptosis. In addition, calmodulin (CaM) antagonist trifluoperazine
(TFP) or silencing CaM attenuated the effects of Cd on MAPK/mTOR activation and cell death. Furthermore, Cd-induced
[Ca
2+]i elevation or CaM activation resulted in induction of reactive oxygen species (ROS). Pretreatment with BAPTA/AM,
EGTA or TFP attenuated Cd-induced ROS and cleavage of caspase-3 in the neuronal cells. Our findings indicate that Cd
elevates [Ca
2+]i, which induces ROS and activates MAPK and mTOR pathways, leading to neuronal apoptosis. The results
suggest that regulation of Cd-disrupted [Ca
2+]i homeostasis may be a new strategy for prevention of Cd-induced
neurodegenerative diseases.
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Introduction
Cadmium (Cd), a toxic transition metal, which can be released
from cigarette smoking, smelting and refining of metals, and
burning of chemical fuels and municipal wastes, results in pollution
of air, water, and soil [1]. As the half-life of Cd in human body is
about 15–20 years [1], chronic exposure to a Cd-contaminated
environment or food chain may cause accumulation of Cd in
various human organs, such as kidney [2], liver [2,3], lung [4,5],
testis, bone and brain [6,7], thereby leading to their damage.
Clinical data have shown that Cd contributes to neurological
disorders such as learning disabilities and hyperactivity in children
[8,9], olfactory dysfunction and neurobehavioral defects in
attention, psychomotor speed, and memory in workers exposed
to Cd [7,10]. Increasing evidence has demonstrated that Cd is a
possible etiological factor of neurodegenerative diseases, such as
Parkinson’s disease, Alzheimer’s disease and amyotrophic lateral
sclerosis [11–13].
Calcium is a ubiquitous intracellular signal responsible for
controlling numerous cellular processes including cell prolifera-
tion, differentiation, and survival/death [14]. Studies have shown
that Cd disrupts intracellular free calcium ([Ca
2+]i) homeostasis,
leading to apoptosis in a variety of cells, such as skin epidermal
cells [15], hepatic cells [16,17], lymphoblastoid cells [16],
mesangial cells [18–20], renal tubular cells [21,22], astrocytes
[23], NIH 3T3 cells [24], thyroid cancer cells [25], and
thymocytes [26]. As a second messenger, Ca
2+ mediates
physiological responses of neurons to neurotransmitters and
neurotrophic factors [27–29]. It has been described that elevation
in cytoplasmic Ca
2+ levels activates the mitogen-activated protein
kinase (MAPK) cascade [15,19] and the phosphatidylinositol 39-
kinase (PI3K)-Akt pathway [29]. Ca
2+ is also critical for amino
acid-mediated activation of mammalian target of rapamycin
(mTOR) [30]. Activation of MAPK and/or mTOR pathways
may promote cell survival or cell death, depending on stimuli [31–
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apoptosis is partially associated with activation of the signaling
pathways involving c-Jun N-terminal kinase (JNK) and extracel-
lular signal-regulated kinase 1/2 (Erk1/2), as well as Akt/mTOR
in neuronal (PC12 and SH-SY5Y) cells [34–36]. However, little is
known about the role of Ca
2+ signaling in Cd-mediated activation
of MAPK/mTOR pathways and apoptosis in neuronal cells.
Increasing evidence indicates that Cd-induced neuronal toxicity
is due to induction of reactive oxygen species (ROS), leading to
oxidative stress [23,35–37]. Under pathological conditions,
excessive amounts of ROS induced by Cd can modify proteins,
lipids and DNA, alter their functions, and activate related
signaling pathways [10,35,38–42]. For example, Cd activates the
MAPK pathway by induction of ROS generation, which not only
activates the upstream kinases of Erk1/2 and JNK, but also
inhibits negative regulators, protein phosphatase 2A (PP2A) and
protein phosphatase 5 (PP5), leading to apoptosis of neuronal cells
[35]. The data suggest that ROS-induced apoptosis is likely to be a
central mechanism of Cd-induced neuronal cell death. It has been
described that Cd-induced ROS is related to [Ca
2+]i elevation in
various types of non-neuronal cells [16,26,43,44]. This prompted
us to study whether Cd induces oxidative stress by disrupting
[Ca
2+]i homeostasis in neuronal cells.
Here we show that Cd-induced neuronal apoptosis is associated
with its induction of [Ca
2+]i elevation in PC12, SH-SY5Y cells and
primary murine neurons. Consequently, Cd-elevated [Ca
2+]i
induces ROS, and activates MAPK and mTOR pathways,
leading to neuronal cell death.
Materials and Methods
Chemicals
Cadmium chloride (Sigma, St. Louis, MO, USA) was dissolved
in sterile distilled water to prepare the stock solutions (0–20 mM),
aliquoted, and stored at room temperature. Fluo-3/AM and Fluo-
4/AM were purchased from Invitrogen (Grand Island, NY, USA).
Poly-D-lysine (PDL), and ethylene glycol tetra-acetic acid (EGTA)
were from Sigma. 1,2-bis-(o-Aminophenoxy)-ethane- N,N,N9,N9-
tetraacetic acid, tetraacetoxymethyl ester (BAPTA/AM) was
purchased from Enzo Life Sciences International (Plymouth
Meeting, PA, USA). Trifluoperazine dihydrochloride (TFP) and
5-(and-6)-chloromethyl-29,79-dichlorodihydrofluorescein diacetate
(CM-H2DCFDA) were from MP Biomedicals (Solon, OH, USA).
Cell culture
Rat pheochromocytoma (PC12) and human neuroblastoma
(SH-SY5Y) cell lines were purchased from American Type
Culture Collection (Manassas, VA, USA), and were used for no
more than 10 and 20 passages, respectively. PC12 cells were
grown in antibiotic-free Dulbecco’s modified Eagle medium
(DMEM) (Mediatech, Herndon, VA, USA) supplemented with
10% horse serum and 5% fetal bovine serum (FBS) (Hyclone,
Logan, UT, USA), whereas SH-SY5Y cells were grown in
antibiotic-free DMEM supplemented with 10% FBS. Cells were
trypsinized with 0.05% Trypsin-EDTA (Invitrogen, Grand Island,
NY, USA), sub-cultured, and maintained in a humid incubator
(37uC, 5% CO2).
Primary murine neurons were isolated from mice as described
[45]. Isolated cells were seeded at a density of 2610
6 cells/well in a
6-well plate coated with 10 mg/ml PDL in NEUROBASAL
TM
Media (Invitrogen) supplemented with 2% B27 Supplement
(Invitrogen), 2 mM glutamine (Invitrogen), 1 mM sodium pyru-
vate (Invitrogen), 5 mg/ml insulin (Sigma), and 40 mg/ml of
gentamicin (Invitrogen), and grown in a humid incubator (37uC,
5% CO2). Fresh medium was replaced every 3 days. The cells
were used for experiments after 6 days of culture.
Lentiviral shRNA cloning, production, and infection
To generate lentiviral short hairpin RNA (shRNA) to
calmodulin (CaM), oligonucleotides containing the target sequenc-
es were synthesized, annealed and inserted into FSIPPW lentiviral
vector via the EcoR1/BamH1 restriction enzyme site, as described
previously [46]. Oligonucleiotides used were: sense: 59-
AATTCCCGGATGGAGATGGCACTATCTG CAAGAGAG-
ATAGTGCCATCTCCATCCTTTTTG-39, anti-sense: 59-GA-
TCCAAA AAGGATGGAGATGGCACTATCTCTCT TGC-
AGATAGTGCCATCTCCATCCGG G-39, which were synthe-
sized by Invitrogen. Lentiviral shRNA construct targeting green
fluorescnec protein (GFP) was described [46]. To produce
lentiviral shRNAs, above constructs were co-transfected together
with pMD2.G and psPAX2 (Addgene, Cambridge, MA, USA) to
293TD cells using Lipfectamine
TM 2000 reagent (Invitrogen).
Each virus-containing medium was collected 36 and 60 h post-
transfection, respectively. For use, monolayer cells, when grown to
about 70% confluence, were infected with above lentivirus-
containing medium in the presence of 8 mg/ml polybrene for
12 h twice at an interval of 6 h. Uninfected cells were eliminated
by exposure to 2 mg/ml puromycin for 48 h before use.
[Ca
2+]i detection
Cells were seeded at a density of 5610
5 cells/well in completed
growth medium in a 6-well plate, precoated with (for PC12) or
without (for SH-SY5Y) PDL (0.2 mg/ml). Next day, cells were
treated with 0–20 mM Cd for 24 h, with 10 and 20 mM Cd for
different time (0–24 h), or with/without 10 and 20 mM Cd for
24 h following pre-incubation with/without BAPTA/AM (30 mM)
and EGTA (100 mM) for 30 min with 6 replicates of each
treatment in PC12 and/or SH-SY5Y cells. The cells were then
trypsinized, washed 3 times with PBS, and resuspended in PBS.
Subsequently, cell suspensions (100 ml) for [Ca
2+]i analysis were
loaded with 5 mM Fluo-3/AM for 30 min at 37uC in the dark,
washed once with PBS to remove the extracellular Fluo-3/AM.
PBS, replacing Fluo-3/AM, served as a negative control. Finally,
the cells for each example were resuspended in 1 ml PBS, followed
by adding the suspension into a 96-well plate (150 ml/well).
Fluorescent intensity was recorded by excitation at 488 nm and
emission at 535 nm using a Synergy
TM 2 Multi-Function
Microplate Reader (Bio-Tek Instruments, Winooski, Vermont,
USA).
To visualize the effect of Cd on [Ca
2+]i in neuronal cells, SH-
SY5Y cells were seeded at a density of 5610
5 cells/well in 6-well
plates containing a glass coverslip per well. Next day, cells were
treated with 0–20 mM Cd for 24 h, with 10 mM Cd for different
time (0–24 h), or with/without 10 mM Cd for 2 and 24 h in the
presence or absence of BAPTA/AM (12.5 mM) or EGTA
(100 mM), followed by removing medium, and washing cells 3
times with PBS. The cells for [Ca
2+]i analysis were loaded with
2.5 mM Fluo-4/AM for 60 min at 37uC in the dark, and then
washed once with PBS to remove the extracellular Fluo-4/AM.
Finally, calcium imaging was acquired with a Nikon Eclipse
TE2000-U inverted fluorescence microscope (Melville, NY, USA)
equipped with a digital camera.
Cell viability assay and morphology
Cells were seeded at a density of 1610
4 cells/well in a flat-
bottomed 96-well plate, precoated with (for PC12 cells and
primary neurons) or without (for SH-SY5Y) PDL. Next day, cells
were treated with 0–20 mM Cd for 24 h, with 10 and 20 mMC d
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24 h following pre-incubation with/without BAPTA/AM (30 mM
for PC12, 12.5 mM for SH-SY5Y, and 20 mM for primary
neurons), 100 mM EGTA, or TFP (50 mM for PC12, 10 mM for
SH-SY5Y, and 20 mM for primary neurons) for 30 min with 4–6
replicates of each treatment. Subsequently, each well was added
20 ml of one solution reagent using CellTiter 96 AQueous One
solution Cell Proliferation Assay kit (Promega, Madison, WI,
USA), and incubated for 3 h. Cell viability was determined by
measuring the optical density (OD) at 490 nm using a Wallac 1420
Multilabel Counter (Perkin-Elmer Life Sciences, Wellesley, MA,
USA).
For cell morphological analysis, cells were seeded at a density of
5610
5 cells/well in a 6-well plate as described above. Next day,
cells were exposed to Cd (10 and 20 mM) in the presence or
absence of BAPTA/AM, EGTA, or TFP at indicated concentra-
tions. After incubation for 24 h, images were taken with a Nikon
Eclipse TE2000-U inverted phase-contrast microscope (Melville,
NY, USA) (2006) equipped with a digital camera.
ROS detection
The ROS level was measured using CM-H2DCFDA, as
described [35]. Briefly, primary neurons and SH-SY5Y cells were
seeded at a density of 1610
4 cells/well in a 96-well plate,
respectively. The next day, cells were treated with Cd (10 and
20 mM) for 24 h in the presence or absence of BAPTA-AM,
EGTA, or TFP at indicated concentrations, followed by
incubation with CM-H2DCFDA for 3 h. Fluorescent intensity
was recorded by excitation at 485 nm and emission at 535 nm
using a Wallac 1420 Multi-label counter (Perkin-Elmer Life
Sciences, Wellesley, MA).
Western blot analysis
Western blot analysis was performed as described [34]. The
following antibodies were used: phospho-Erk1/2 (Thr202/
Tyr204), phospho-p38 (Thr180/Tyr182), phospho-Akt (Ser473),
phospho-S6K1 (Thr389), phospho-mTOR (Ser2448), mTOR,
4E-BP1, caspase-3, cleaved caspase-3 (Asp175), cleaved PARP
(Asp214) (Cell Signaling Technology, Beverly, MA, USA), JNK1,
phospho-JNK (Thr183/Tyr185), c-Jun, phospho-c-Jun (Ser63),
Erk2, p38, Akt, S6K1, CaM (Santa Cruz Biotechnology, Santa
Cruz, CA, USA), b-tubulin (Sigma, MO), goat anti-rabbit IgG-
horseradish peroxidase (HRP), goat anti-mouse IgG-HRP, and
rabbit anti-goat IgG-HRP (Pierce, Rockford, IL, USA). Enhanced
chemiluminescence solution was from Pierce.
Statistical analysis
Results were expressed as mean values 6 standard error (mean
6 S.E.). Statistical analysis was performed by Student’s t test
(STATISTICA, Statsoft Inc., Tulsa, OK, USA). A level of P,0.05
was considered to be statistically significant.
Results
Cd induces intracellular [Ca
2+]i elevation in neuronal cells
To determine the role of calcium signaling in Cd-induced
neuronal apoptosis, PC12 and SH-SY5Y cells, respectively, were
treatedwith 0–20 mM Cd for24 h,or with 10 and 20 mM Cd for 0–
24 h. Subsequently, [Ca
2+]i was measured with a calcium indicator
dye, Fluo-3/AM or Fluo-4/AM. We found that treatment with Cd
(0–20 mM) resulted in a concentration-dependent increase of
[Ca
2+]i in PC12 cells (Fig. 1A). Cd also induced a time-dependent
elevation of [Ca
2+]i in the cells during the period of 24 h (Fig. 1B).
Similarly, Cd markedly elicited high [Ca
2+]i fluorescence intensity
in a concentration- and time-dependent manner in SH-SY5Y cells
by fluorescence microscopy (Fig. 1C and D). Furthermore, Cd-
elevated [Ca
2+]i level was consistent with decreased cell viability
(Fig. 1E and F) or increased apoptosis of PC12 and SH-SY5Y cells
[35], suggesting that Cd-induced neuronal apoptosis might be
associated with its induction of [Ca
2+]i elevation.
Cd elevated [Ca
2+]i activates MAPK and mTOR pathways
leading to apoptosis in neuronal cells
To validate the pivotal role of [Ca
2+]i elevation in Cd-induced
neuronal apoptosis, PC12 cells were pretreated with/without
30 mM BAPTA/AM, an intracellular Ca
2+ chelator, for 30 min,
and then exposed to Cd (10 and 20 mM) for 24 h. We found that
pretreatment with BAPTA/AM significantly blocked Cd-triggered
[Ca
2+]i elevation (Fig. 2A). Similar results were also seen in SH-
SY5Y cells (Fig. 2B). One-solution assay showed that BAPTA/AM
partially prevented Cd-decreased cell viability in PC12, SH-SY5Y
cells and primary neurons (Fig. 2C). The results demonstrate that
Cd induces neuronal apoptosis through induction of [Ca
2+]i
elevation.
Recently we have demonstrated that Cd induces apoptosis of
PC12 and SH-SY5Y cells via activation of MAPK and mTOR
signaling network [34]. To examine whether Cd-induced [Ca
2+]i
elevation is correlated to the activation of MAPK and mTOR
pathways, PC12, SH-SY5Y, and primary neurons were preincu-
bated with/without BAPTA/AM for 30 min, followed by
treatment with Cd (10 and 20 mM) for 4 h. Western blot analysis
showed that BAPTA/AM significantly blocked Cd-induced
phosphorylation of JNK, Erk1/2, and p38 MAPK (Fig. 2D), as
well as phosphorylation of mTOR, and mTOR-mediated S6K1
and 4E-BP1 (Fig. 2E). It should be mentioned that phosphoryla-
tion state of 4E-BP1 was detected with an antibody to 4E-BP1.
Phosphorylation of 4E-BP1 decreases its electrophoretic mobility
during sodium dodecyl sulfate-polyacrylamide gel electrophoresis
[34]. As shown in Fig. 2E, Cd increased phosphorylation of 4E-
BP1, as indicated by the increase in the intensity of the uppermost
band c and by the decrease in the higher mobility band a and b
that corresponds to a less phosphorylated form of 4E-BP1.
Consistently, we also noticed that Cd-activated Akt as the main
upstream mediator of mTOR signaling was also partially
abrogated by BAPTA/AM in PC12 cells and primary neurons
(Fig. 2E). These results unveil that Cd induction of [Ca
2+]i
elevation activates the MAPK and mTOR pathways, triggering
apoptosis of the neuronal cells.
Cd-induced extracellular Ca
2+ influx elevates [Ca
2+]i
contributing to neuronal apoptosis via activation of
MAPK and mTOR pathways
To investigate the role of extracellular Ca
2+ in Cd-induced
neuronal apoptosis, EGTA, an extracellular Ca
2+ chelator, was
utilized. As shown in Fig. 3A and B, pretreatment with 100 mM
EGTA for 30 min almost completely abolished [Ca
2+]i elevation
induced by 10 and 20 mM Cd in PC12 or SH-SY5Y cells.
Consistently, we observed that Cd alone (10 and 20 mM) induced
cell roundup and shrinkage, and EGTA itself did not alter cell
shape. However, EGTA obviously blocked Cd-induced morpho-
logical change (Fig. 3C). One-solution assay showed that EGTA
significantly attenuated Cd-decreased cell viability in SH-SY5Y
cells, and primary neurons (Fig. 3D). The findings suggest that Cd
elevates [Ca
2+]i at least in part by increasing extracellular Ca
2+
influx, leading to apoptosis of neuronal cells.
To determine the effects of extracellular Ca
2+ on MAPK and
mTOR pathways, PC12, SH-SY5Y, and primary neurons were
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Cd for 4 h, followed by Western blot analysis. We found that
EGTA blocked Cd-induced phosphorylation of Erk1/2, JNK, and
p38 MAPK (Fig. 3E), as well as phosphorylation of Akt/mTOR
pathways (Fig. 3F). The results indicate that Cd may elevate
[Ca
2+]i in neuronal cells partially by increasing extracellular Ca
2+
influx, leading to neuronal apoptosis via activation of MAPK and
mTOR pathways.
Cd-elevated [Ca
2+]i activates MAPK/mTOR pathways and
apoptosis in neuronal cells through calcium-binding
protein CaM
CaM, a multifunctional Ca
2+-binding protein, acts as a
transducer of the intracellular calcium signal for a variety of
cellular events, including apoptosis [14,29]. Many proteins that
CaM binds cannot bind calcium themselves, and have to use CaM
as a calcium sensor and signal transducer [14,29]. We proposed
that Cd-elevated [Ca
2+]i activates MAPK/mTOR pathways and
induces neuronal apoptosis through CaM. To test this hypothesis,
PC12 and SH-SY5Y cells were pretreated with CaM antagonist
TFP (50 mM for PC12 or 10 mM for SH-SY5Y) for 30 min, and
then exposed to Cd (10, 20 mM) for 24 h, followed by Western
blotting and cell viability assay. The results showed that TFP
partially blocked Cd-induced phosphorylation of Erk1/2, JNK,
and p38 in PC12, SH-SY5Y and primary neurons (Fig. 4A). Cd-
activated phosphorylation of Akt, mTOR, S6K and 4E-BP1 in
PC12 cells and primary neurons was also significantly reduced by
TFP (Fig. 4B). One-solution assay revealed that TFP significantly
attenuated Cd-decreased cell viability in PC12, SH-SY5Y and
primary neurons (Fig. 4C).
To substantiate the role of CaM in Cd-induced activation of
MAPK/mTOR and apoptosis in neuronal cells, CaM was
silenced by RNA interference technology. As shown in Fig. 5A,
lentiviral shRNA to CaM downregulated protein expression of
CaM by ,90% in PC12 cells, compared with the control shRNA
to GFP. Silencing CaM remarkably inhibited Cd-induced
phosphorylation of MAPK and Akt/mTOR pathways in PC12
cells (Fig. 5A and B). Importantly, downregulation of CaM
obviously attenuated Cd inhibition of cell viability (Fig. 5C and D).
The results indicate that Cd-elevated [Ca
2+]i activates MAPK/
mTOR network and induces apoptosis in neuronal cells through
CaM.
Cd-elevated [Ca
2+]i induces ROS, triggering apoptosis of
neuronal cells
Recently we have demonstrated that Cd-induced neuronal
apoptosis is attributed to induction of ROS [35,36]. In this study,
we have shown that Cd induces apoptosis of PC12 and SH-SY5Y
cells due to [Ca
2+]i elevation (Fig. 1). Therefore, next we sought to
test whether Cd-elevated [Ca
2+]i contributes to ROS induction,
leading to cell death. To this end, SH-SY5Y and primary neuron
cells were pretreated with/without BAPTA/AM or EGTA for
30 min, respectively, and then exposed to 10 and 20 mM Cd for
24 h. As shown in Fig. 2 and Fig. 3, pretreatment with BAPTA/
AM or EGTA inhibited Cd-induced [Ca
2+]i elevation. Exposure
to Cd (10 and 20 mM) for 24 h increased ROS levels by
approximately 1.5–4.5 fold in SH-SY5Y cells and by 1.4–2.0 fold
in primary neurons, respectively (Fig. 6A and B). Interestingly,
pretreatment with BAPTA/AM or EGTA alone did not obviously
alter the basal level of ROS, but strikingly attenuated Cd induction
of ROS (Fig. 6A and B). Similarly, pretreatment with CaM
antagonist TFP also profoundly attenuated Cd induction of ROS
in SH-SY5Y and primary neurons (Fig. 7A), suggesting involve-
ment of CaM. This was further confirmed by silencing CaM in
PC12 and SH-SY5Y cells (Fig. 7B). In addition, we further noticed
that treatment of PC12 cells with 20 mM Cd for 24 h resulted in
robust activation of caspase-3, as detected by decreased pro-
caspase-3, and increased cleavage of caspase-3 (Fig. 8). Activation
of caspase-3 also enhanced cleavage of poly (ADP-ribose)
polymerase (PARP) (Fig. 8), indicating apoptosis. As expected,
BAPTA/AM, EGTA or TFP obviously attenuated Cd-induced
cleavages of caspase-3 and PARP in the cells (Fig. 8), which is
agreement with our findings that BAPTA/AM, EGTA or TFP
profoundly prevented Cd-induced apoptosis of PC12 cells (Fig. 2,
3 and 4). Similar results were observed in SH-SY5Y cells (data not
shown). These data suggest that Cd elevates [Ca
2+]i level, which
induces ROS, triggering apoptosis in neuronal cells.
Discussion
Calcium has been recognized as a ubiquitous intracellular signal
responsible for numerous cellular events, such as growth,
proliferation, differentiation, and survival/apoptosis [14]. As a
second messenger, Ca
2+ mediates responses of neurons to
neurotransmitters and neurotrophic factors, including cell survival
or death signals [27–29]. Dysfunction of cellular Ca
2+ homeostasis
induces neuronal cell death, which is implicated in many
neurodegenerative disorders, such as Alzheimer’s disease and
Parkinson’s diseases [47–50]. Here, for the first time, we present
evidence that Cd elevates [Ca
2+]i level, thereby activating MAPK/
mTOR pathways, leading to apoptosis in PC12, SH-SY5Y cells
and primary murine neurons. Our results are in line with the
previous findings [15–26]. It has been described that Cd disrupts
[Ca
2+]i homeostasis, causing apoptosis in a variety of non-
neuronal cells, including skin epidermal cells [15], hepatic cells
[16,17], lymphoblastoid cells [16], mesangial cells [18–20], renal
tubular cells [21,22], NIH 3T3 cells [24], thyroid cancer cells [25],
and thymocytes [26], as well as brain glial cells (astrocytes) [23].
Cd-increased cytoplasmic Ca
2+ activates p38 in mesangial cells
[19] and JNK in skin epidermal cells [15]. Cd-elevated [Ca
2+]i can
also activate PI3K/Akt in thyroid carcinoma cells [25]. In the
present study, we found that Cd-elevated [Ca
2+]i activated JNK,
p38, Erk1/2, Akt and mTOR in PC12, SH-SY5Y cells and
murine primary neurons. A new question that arises from the
current work is whether Cd-elevated [Ca
2+]i activates MAPKs and
PI3K-Akt-mTOR pathways is a cell type context or a general
mechanism in all mammalian cells.
Because [Ca
2+]i increase is usually caused by Ca
2+ mobilization
from intracellular stores and/or Ca
2+ entry from the extracellular
space [14], we investigated the source of [Ca
2+]i induced by Cd. In
this study, we observed that Cd-induced [Ca
2+]i elevation in PC12
and SH-SY5Y cells was almost completely abolished by EGTA
(Fig. 3), an extracellular Ca
2+ chelator, which renders the
Figure 1. Cd-induced neuronal apoptosis is associated with induction of [Ca
2+]i elevation. (A and B) PC12 cells were treated with 0–20 mM
Cd for 24 h, or with 0, 10 and 20 mM Cd for 0–24 h, and then loaded with 5 mM Fluo-3/AM for 30 min at 37uC in the dark, followed by measurement
of [Ca
2+]i fluorescence intensity, as described in Materials and Methods. (C and D) SH-SY5Y cells were exposed to 0–20 mM Cd for 24 h, or 10 mMC d
for 0–24 h, and then loaded with 2.5 mM Fluo-4/AM for 60 min at 37uC in the dark, followed by recording of the images under a fluorescence
microscope. (E and F) Cell viability of PC12 cells, treated with 0–20 mM Cd for 24 h or with 20 mM Cd for 0–24 h, was evaluated by one solution assay.
Results are presented as mean 6 SE; n=6.
**P,0.01 difference vs. control group.
doi:10.1371/journal.pone.0019052.g001
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PLoS ONE | www.plosone.org 5 April 2011 | Volume 6 | Issue 4 | e19052Figure 2. Cd activates MAPK/mTOR pathways and neuronal apoptosis via induction of [Ca
2+]i elevation. Indicated cells were pretreated
with/without BAPTA/AM at indicated concentrations for 30 min, and then exposed to Cd (10 and/or 20 mM) for 24 h (A–C) or 4 h (D, E). (A) [Ca
2+]i in
PC12 cells was determined by measuring Fluo-3/AM-labeled fluorescent intensity, as described in Materials and Methods. (B) [Ca
2+]i was stained with
Fluo-4/AM and visualized by fluorescence microscopy in SH-SY5Y cells. (C) Cell viability for PC12, SH-SY5Y, and primary neurons was evaluated using
one solution assay. (D and E) Indicated cell lysates were subjected to Western blotting using indicated antibodies. The blots were probed for b-
tubulin as a loading control. Similar results were observed in at least three independent experiments. Results (A and C) are presented as mean 6 SE;
n=6.
bP,0.01, difference vs. control group;
cP,0.01, difference vs. 10 mM Cd group;
dP,0.01, difference vs. 20 mM Cd group.
doi:10.1371/journal.pone.0019052.g002
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2+ to the cells. Consistently,
EGTA also blocked Cd-induced phosphorylation of MAPK and
mTOR pathways, and dramatically attenuated the toxicity of Cd
in SH-SY5Y and primary neurons (Fig. 3). The findings indicate
that Cd may elevate [Ca
2+]i in neuronal cells in part by increasing
extracellular Ca
2+ influx, leading to neuronal apoptosis via
activation of MAPK and mTOR pathways. It is worthy
mentioning that during the studies, we also observed that
pretreatment with 2-aminoethoxydiphenyl borate, a membrane-
permeable inhibitor of inositol trisphosphate receptor [51],
markedly attenuated Cd-induced [Ca
2+]i elevation, and partially
blocked Cd-activated Erk1/2, JNK, p38 and mTOR pathways, as
well as neuronal apoptosis (data not shown), suggesting that Cd-
induced [Ca
2+]i elevation may involve induction of intracellular
release of Ca
2+ storage as well.
CaM, a Ca
2+-binding protein, functions as a calcium signal
transducer [14]. Many enzymes that cannot bind calcium have to
use CaM as a calcium sensor [14,29]. Inhibition of CaM by the
antagonists, such as TFP and Tamoxifen, prevents CD4+ T-cells
from HIV-induced apoptosis [52]. However, little is known about
the role of CaM in Cd-induced neuronal apoptosis. To better
understand how calcium regulates Cd-mediated neurotoxicity, we
further studied CaM. Since most recently we have found that Cd
upregulates ROS generating enzyme NADPH oxidase 2 and its
regulatory proteins [36], originally, we speculated that Cd might
activate CaM function not only by increasing Ca
2+ binding but
Figure 4. Inhibition of CaM by TFP attenuates Cd activation of MAPK/mTOR and apoptosis in neuronal cells. Indicated cells were
pretreated with/without TFP at indicated concentrations for 30 min, and then exposed to Cd (10 and 20 mM) for 4 h (A, B) or 24 h (C). (A and B)
Indicated cell lysates were subjected to Western blotting using indicated antibodies. The blots were probed for b-tubulin as a loading control. Similar
results were observed in at least three independent experiments. (C) Cell viability for indicated cells was evaluated using one solution assay. Results
are presented as mean 6 SE; n=6.
aP,0.05,
bP,0.01, difference vs. control group;
cP,0.01, difference vs. 10 mM Cd group;
dP,0.01, difference vs.
20 mM Cd group.
doi:10.1371/journal.pone.0019052.g004
Figure 3. Cd-induced extracellular Ca
2+ influx elevates [Ca
2+]i contributing to neuronal apoptosis via activation of MAPK and mTOR
pathways. Indicated cells were pretreated with or without 100 mM EGTA for 30 min, and then exposed to Cd (10 and/or 20 mM) for 24 h (A–D) or 4 h
(E, F). (A and B) [Ca
2+]i fluorescent intensities were evaluated as described in Materials and Methods. (C) Morphology of PC12 cells was assessed using
a Nikon Eclipse TE2000-U inverted phase-contrast microscope (2006) equipped with digital camera. (D) Cell viability in SH-SY5Y cells and primary
neurons was evaluated by one solution assay. (E and F) Indicated cell lysates were subjected to Western blotting using indicated antibodies. The blots
were probed for b-tubulin as a loading control. Similar results were observed in at least three independent experiments. Results (A, D) are presented
as mean 6 SE; n=6.
bP,0.01, difference vs. control group;
cP,0.01, difference vs. 10 mM Cd group;
dP,0.01, difference vs. 20 mM Cd group.
doi:10.1371/journal.pone.0019052.g003
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neuronal apoptosis. However, to our surprise, exposure to Cd (10
or 20 mM) for 24 h did not alter protein expression of CaM in
PC12 and SH-SY5Y cells (data not shown). As expected,
pretreatment with CaM antagonist TFP, which reduces Ca
2+
binding to CaM [53], did significantly attenuate Cd-induced
activation of MAPK and mTOR pathways, as well as cell death in
PC12, SH-SY5Y and primary neurons (Fig. 4). Similarly, silencing
CaM with lentiviral shRNA to CaM also remarkably prevented
Cd-induced activation of MAPK and mTOR network, as well as
cell death in PC12 cells (Fig. 5). Therefore, our data support the
notion that Cd induces neuronal apoptosis through Ca
2+/CaM-
mediated activation of MAPK and mTOR pathways.
In the study, we noticed that Cd-induced [Ca
2+]i elevation did
not alter total cellular protein expression of JNK1/2, but
preferentially induced p-JNK1 (the lower band), which is
particularly obvious in PC12 cells (Fig. 5). Also, activation of
JNK1, bot not JNK2 (the upper band), is critical for phosphor-
ylation of c-Jun (Fig. 5). It appears that CaM plays a critical role in
this process. This is strongly supported by the findings that
silencing CaM by shRNA dramatically blocked Cd-induced p-
JNK1, but not p-JNK2, abrogating Cd-induced phosphorylation
of c-Jun and attenuating Cd-induced cell death (Fig. 5). The results
support the notion that JNK1 and JNK2 are regulated by different
mechanisms, and have distinct signaling functions. Similar finding
has been documented in myeloid leukemia cells [54]. JNK1
positively regulates vitamin D (1,25-dihydroxyvitamin D3)-induced
differentiation in HL60 and U937 cells, but JNK2 negatively
regulates this process, which is associated with activation of c-Jun
and other transcription factors [54]. Furthermore, we also
observed that c-Jun cellular protein level is correlated to its
phosphorylation status. When c-Jun was phosphorylated, high
level of c-Jun was detected (Fig. 2, 3, 4, 5). This is consistent with
previous findings that phosphorylation of c-Jun by JNK protects c-
Jun from ubiquitination and prolongs its half-life [55].
Currently we do not know what isoforms of p38 MAPK is
activated by Cd-induced [Ca
2+]i elevation. Four isoforms of p38
(a,- b,- c, and -d) have been identified [56]. Of importance,
various isoforms of p38 have unique cellular functions [56–58]. In
the study, an antibody to phospho-p38 (Thr180/Tyr182) (Cat.#
9215, Cell Signaling) was used, which cannot differentiate isoforms
of p38a,- b,- c, and -d. Our previous studies have demonstrated
Figure 5. Downregulation of CaM attenuates Cd activation of MAPK/mTOR pathways and apoptosis in neuronal cells. PC12 Cells
infected with lentiviral shRNAs to CaM and GFP, respectively, were exposed to Cd (0–20 mM) for 4 h (A,B) or 24 h (C,D), followed by Western blotting
with indicated antibodies (A, B), cell morphological analysis (C) or cell viability assay (D), as described in Materials and Methods. Note: CaM was
downregulated by ,90% by lentiviral shRNA to CaM, compared with the control (lentiviral shRNA to GFP), by densitometry using NIH Image J. Results
are presented as mean 6 SE; n=6.
aP,0.01, difference vs. control group;
bP,0.01, CaM shRNA group vs. GFP shRNA group.
doi:10.1371/journal.pone.0019052.g005
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2+]i induces ROS in neuronal cells. Indicated cells were exposed to 0–20 mM Cd for 24 h after pretreatment with/
without indicated concentrations of BAPTA/AM (A) or EGTA (B) for 30 min, followed by ROS detection, as described in Materials and Methods. Results
are presented as mean 6 SE; n=6.
aP,0.05,
bP,0.01, difference vs. control group;
cP,0.01, difference vs. 10 mM Cd group;
dP,0.01, difference vs.
20 mM Cd group.
doi:10.1371/journal.pone.0019052.g006
Figure 7. CaM is essential for Cd induction of ROS in neuronal cells. Indicated cells pretreated with/without TFP at indicated concentrations
for 30 min (A), or infected with lentiviral shRNAs to CaM and GFP, respectively (B), were exposed to 0–20 mM Cd for 24 h, followed by ROS detection,
as described in Materials and Methods. Results are presented as mean 6 SE; n=6.
aP,0.01, difference vs. control group;
bP,0.01, difference vs.
10 mM Cd group;
cP,0.01, difference vs. 20 mM Cd group;
dP,0.01, CaM shRNA group vs. GFP shRNA group.
doi:10.1371/journal.pone.0019052.g007
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neuronal cell death [34]. Further studies may not only help
identify what isoforms of p38 MAPK is activated by Cd, but also
elucidate the potential role of the specific isoforms of p38
activation in neuronal cells.
We are puzzled that Cd activation of Akt/mTOR signaling
pathways promotes neuronal cell death. It is commonly accepted
that mTOR is a master kinase, which positively regulates protein
synthesis, cell growth, proliferation and survival [32,59]. In our
studies, we have found that under different stress conditions, the
consequence of activation of Akt/mTOR pathway in neuronal
cells is completely different [34–36,45]. In response to hydrogen
peroxide, mTOR pathway was persistently (.24 h) inhibited, and
overexpression of mTOR attenuated hydrogen peroxide-induced
neuronal apoptosis [45], suggesting that certain level of mTOR
activation is essential for neuronal cell survival. On the other hand,
in response to Cd, mTOR was sustainably (.24 h) activated, and
pretreatment with rapamycin, an mTOR inhibitor, blocked Cd-
induced phosphorylation of S6K1 and 4E-BP1, and markedly
attenuated Cd-induced apoptosis [34]. The results imply that
sustained hyper-activation of mTOR is actually not beneficial, but
detrimental to neuronal cells, particularly under oxidative stress.
As mTOR controls Cap-dependent translation [32,59], we
speculate that Cd activation of mTOR would enhance protein
synthesis in the cells, which may consume a lot of energy (ATP)
and meanwhile generate much ROS. If mTOR is persistently
activated, too much ATP will be consumed and too much ROS
will be generated, leading to cell death.
Cd is a well-known inducer of ROS generation in cells [60].
Recently, we have shown that Cd induced ROS generation in a
time- and concentration-dependent manner in PC12 and SH-
SY5Y cells [35], which causes apoptosis of neuronal cells via
activation of MAPKs and mTOR signaling pathways [34–36].
However, whether Cd-induced [Ca
2+]i signaling is involved in
these events remains enigmatic. Here, we show that chelation of
calcium with BAPTA/AM or EGTA (Fig. 6) or inhibition of CaM
with TFP or CaM shRNA (Fig. 7) dramatically attenuated Cd-
induced ROS in SH-SY5Y, PC12 or primary neurons. Further-
more, we also observed that BAPTA/AM, EGTA and TFP could
obviously reduce cleavages of caspase-3 and PARP in Cd-induced
PC12 cells (Fig. 8), which is agreement with our finding that
BAPTA/AM, EGTA or TFP was able to strikingly prevent Cd-
induced neuronal cell death (Fig. 2 and 3). These data reveal that
Cd-induced apoptosis of neuronal cells is triggered by elevated
[Ca
2+]i, leading to ROS induction and subsequent activation of
caspase signaling pathway.
In summary, here we have shown that Cd-induced [Ca
2+]i
elevation, which was implicated in increased CaM function,
induced ROS and activated MAPK and mTOR pathways,
thereby leading to caspase-dependent apoptosis of neuronal cells.
Cd-induced extracellular Ca
2+ influx appears to play a critical role
in contributing to neuronal apoptosis. Regulation of Cd-disrupted
[Ca
2+]i homeostasis may have a potential for prevention of Cd-
induced neurodegenerative diseases.
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